Edgestream Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-94,748
Closed -$1.75M 1035
2025
Q2
$1.75M Sell
94,748
-61,648
-39% -$1.09M 0.05% 555
2025
Q1
$2.73M Buy
156,396
+6,696
+4% +$113K 0.09% 407
2024
Q4
$2.59M Buy
+149,700
New +$2.73M 0.11% 337
2024
Q1
Sell
-75,330
Closed -$1.07M 994
2023
Q4
$1.07M Buy
+75,330
New +$1.07M 0.08% 426
2023
Q2
Sell
-162,946
Closed -$1.87M 894
2023
Q1
$1.87M Sell
162,946
-8,505
-5% -$105K 0.21% 158
2022
Q4
$2.13M Buy
171,451
+28,693
+20% +$366K 0.24% 139
2022
Q3
$1.87M Buy
+142,758
New +$2.11M 0.14% 204

Other funds holding SBRA

Edgestream Partners's SBRA Position: Q3 2025 in Review

Edgestream Partners sold out of Sabra Healthcare REIT (SBRA) in Q3 2025, closing a stake of 94,748 shares — an estimated $1.75M sold.

Edgestream Partners first reported a position in SBRA in Q3 2022 and held it in 7 quarters. The position peaked at $2.73M in Q1 2025. 424 funds tracked by Wall St. Rank hold SBRA as of Q3 2025.

  • Edgestream Partners reported no remaining Sabra Healthcare REIT position as of Q3 2025 after selling out during the quarter.
  • Edgestream Partners sold 94,748 Sabra Healthcare REIT shares in Q3 2025, an estimated $1.75M.
  • Edgestream Partners first reported a position in Sabra Healthcare REIT in Q3 2022 and held it in 7 quarters.
  • Edgestream Partners's Sabra Healthcare REIT position peaked at $2.73M in Q1 2025.
  • 424 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2025.

Based on Edgestream Partners's 13F filing for Q3 2025, filed 12 Nov 2025.